FIA
DRTS icon

FNY Investment Advisers’s Alpha Tau Medical DRTS Stock Holding History

FNY Investment Advisers’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+40
New +$363 ﹤0.01% 910

Other funds holding DRTS

AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
FGG
Financial Guidance Group Palm Harbor, Florida $267M AUM 19.62% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
WC
Waterloo Capital Austin, Texas $1.78B AUM 27.25% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $227M AUM 41.04% 1-Year Est. Return

FNY Investment Advisers's DRTS Position: Q2 2026 in Review

FNY Investment Advisers opened a new position in Alpha Tau Medical (DRTS) in Q2 2026: 40 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #910 among its holdings.

15 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • FNY Investment Advisers held 40 shares of Alpha Tau Medical worth $0 as of Q2 2026.
  • Alpha Tau Medical was a new FNY Investment Advisers position in Q2 2026.
  • Alpha Tau Medical made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #910 holding.
  • 15 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.